NO914077L - Galaktomannanderivater for omhylling eller innleiring av aktive bestanddeler i legemidler - Google Patents

Galaktomannanderivater for omhylling eller innleiring av aktive bestanddeler i legemidler

Info

Publication number
NO914077L
NO914077L NO91914077A NO914077A NO914077L NO 914077 L NO914077 L NO 914077L NO 91914077 A NO91914077 A NO 91914077A NO 914077 A NO914077 A NO 914077A NO 914077 L NO914077 L NO 914077L
Authority
NO
Norway
Prior art keywords
galactom
pharmaceuticals
inhibition
derivatives
environment
Prior art date
Application number
NO91914077A
Other languages
English (en)
Other versions
NO914077D0 (no
Inventor
Kurt Heinz Bauer
Christian Wohlschlegel
Antonis Sarlikiotis
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of NO914077D0 publication Critical patent/NO914077D0/no
Publication of NO914077L publication Critical patent/NO914077L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0087—Glucomannans or galactomannans; Tara or tara gum, i.e. D-mannose and D-galactose units, e.g. from Cesalpinia spinosa; Tamarind gum, i.e. D-galactose, D-glucose and D-xylose units, e.g. from Tamarindus indica; Gum Arabic, i.e. L-arabinose, L-rhamnose, D-galactose and D-glucuronic acid units, e.g. from Acacia Senegal or Acacia Seyal; Derivatives thereof
    • C08B37/0093—Locust bean gum, i.e. carob bean gum, with (beta-1,4)-D-mannose units in the main chain branched with D-galactose units in (alpha-1,6), e.g. from the seeds of carob tree or Ceratonia siliqua; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Botany (AREA)
  • Emergency Medicine (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Displays For Variable Information Using Movable Means (AREA)
  • Two-Way Televisions, Distribution Of Moving Picture Or The Like (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
NO91914077A 1990-10-18 1991-10-17 Galaktomannanderivater for omhylling eller innleiring av aktive bestanddeler i legemidler NO914077L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4033041 1990-10-18

Publications (2)

Publication Number Publication Date
NO914077D0 NO914077D0 (no) 1991-10-17
NO914077L true NO914077L (no) 1992-04-21

Family

ID=6416524

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91914077A NO914077L (no) 1990-10-18 1991-10-17 Galaktomannanderivater for omhylling eller innleiring av aktive bestanddeler i legemidler

Country Status (18)

Country Link
EP (1) EP0481240B1 (no)
JP (1) JP3020684B2 (no)
KR (1) KR920008060A (no)
AT (1) ATE146191T1 (no)
AU (1) AU636800B2 (no)
BR (1) BR9104502A (no)
CA (1) CA2053569A1 (no)
CS (1) CS315091A3 (no)
DE (2) DE59108407D1 (no)
ES (1) ES2095894T3 (no)
FI (1) FI914909A (no)
HU (1) HUT58263A (no)
IE (1) IE913649A1 (no)
IL (1) IL99760A0 (no)
MC (1) MC2280A1 (no)
NO (1) NO914077L (no)
PT (1) PT99254A (no)
ZA (1) ZA918292B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4119306C2 (de) * 1991-06-12 1996-05-30 Wheli Inter Ag Organische Rohstoffe, Zwischen- und Endprodukte für die Ernährung und zur Verwendung für technische Zwecke, die Vitalstoffe enthalten
FR2688422A1 (fr) * 1992-03-11 1993-09-17 Coletica Microcapsules a parois en polysaccharides contenant des fonctions alcools primaires, et compositions en contenant.
DE4236025A1 (de) 1992-10-24 1994-04-28 Merck Patent Gmbh Orale Arzneiformen
US5459257A (en) * 1993-01-11 1995-10-17 Dainippon Ink And Chemicals, Inc. Sulfated oligoglycoside acylate and antiviral agent containing the same as active ingredient
IT1265092B1 (it) * 1993-05-31 1996-10-30 Giuliani Spa Preparato per uso come integratore alimentare, o dietetico,a rilascio mirato nel colon
US5872246A (en) * 1994-10-17 1999-02-16 Aqualon Company Ethyl guar
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
US5656294A (en) * 1995-06-07 1997-08-12 Cibus Pharmaceutical, Inc. Colonic delivery of drugs
FR2746011B1 (fr) * 1996-03-12 1998-04-24 Composition gelifiee stable contenant des actifs lipophiles sensibles a l'oxygene et/ou a l'eau et son utilisation dans les domaines cosmetique, et/ou dermatologique
FR2768357B1 (fr) 1997-09-18 1999-11-05 Snecma Procede d'assemblage ou de rechargement par brasage-diffusion de pieces en aluminiure de titane
DE102011082716A1 (de) * 2011-09-14 2013-03-14 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Indikatorelement mit einer von einer in kontakt zu bringenden substanz abhängigen farbgebung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB498149A (en) * 1937-07-29 1939-01-04 Ig Farbenindustrie Ag Improvements in the conversion of constituents of carob beans
DE1617626C3 (de) * 1966-08-30 1975-02-13 Merck Patent Gmbh, 6100 Darmstadt Verwendung von Galaktomannanen zur Stabilisierung fester, wasserlöslicher Vitamin B tief 12 -Zubereitungen
DE2130545A1 (de) * 1971-06-19 1972-12-21 Merck Patent Gmbh Pharmazeutischer Formkoerper

Also Published As

Publication number Publication date
IL99760A0 (en) 1992-08-18
KR920008060A (ko) 1992-05-27
ES2095894T3 (es) 1997-03-01
DE4131292A1 (de) 1992-04-23
JPH04264102A (ja) 1992-09-18
HU913245D0 (en) 1992-01-28
CS315091A3 (en) 1992-05-13
BR9104502A (pt) 1992-06-09
ATE146191T1 (de) 1996-12-15
FI914909A (fi) 1992-04-19
FI914909A0 (fi) 1991-10-17
NO914077D0 (no) 1991-10-17
MC2280A1 (fr) 1993-06-23
CA2053569A1 (en) 1992-04-19
EP0481240A2 (de) 1992-04-22
HUT58263A (en) 1992-02-28
ZA918292B (en) 1992-07-29
DE59108407D1 (de) 1997-01-23
IE913649A1 (en) 1992-04-22
AU636800B2 (en) 1993-05-06
EP0481240B1 (de) 1996-12-11
JP3020684B2 (ja) 2000-03-15
PT99254A (pt) 1992-08-31
EP0481240A3 (en) 1993-04-21
AU8595791A (en) 1992-05-21

Similar Documents

Publication Publication Date Title
DE69412250D1 (de) Pyridobismidazole enthaltendes rigid-rod-Polymer
FI853198L (fi) Farmaceutiska kompositioner innehaollande i vatten instabila eller begraensat loesliga laekemedel och foerfarande foer framstaellning av dem.
DE69310518D1 (de) Pharmazeutische zusammensetzung zur topischen anwendung die ein vernetztes kationisches polymer und einen alkoxylierte äther enthält
FR2680512B1 (fr) Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
KR950016783A (ko) 조절 방출용 약학 조성물
ES2118834T3 (es) Sistema mejorado de penetracion en la piel para la administracion topica mejorada de farmacos.
NO914077D0 (no) Galaktomannanderivater for omhylling eller innleiring av aktive bestanddeler i legemidler
FI935273A0 (fi) En farmaceutisk komposition innnehaollande ett definierat lipidsystem
ATE113604T1 (de) Mometason-furoate-monohydrat, verfahren zu seiner herstellung und das enthaltende pharmazeutische zusammensetzungen.
GB2334446B (en) Aqueous compositions compromising a lipid and a lanolin-derived surfactant,and their use
HRPK990402B1 (hr) Farmaceutski pripravci za primjenu na sluznici
YU92192A (sr) Postupak za dobijanje preparata soli lipofilnih oligosaharidnih antibiotika
FR2679906B1 (fr) Nouvelles (isoquinolein-5 yl) sulfonamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
KR920009419A (ko) 키토산을 함유하는 혼화성 블렌드
DE69710959T2 (de) Verwendung eines Polysaccharids zur Stimulierung der Immunabwehr
ATE160938T1 (de) Feste orale pharmazeutische zubereitung mit gemfibrozil als aktiver inhaltsstoff und verfahren zur herstellung
FR2665179B1 (fr) Procede d'hydroxylation d'un radical methylene acyclique ou cyclique en position allylique, composition pharmaceutique contenant des esters d'hydroxycholesterol et utilisation de ces compositions pour la preparation de medicaments.
KR970032876A (ko) 간장질환 치료용 의약 조성물
MX9307009A (es) Derivados de 5-[(imidaol{4,5-b}piridin-3-il]metil/benzofurano, procesopara su preparacion y composiciones farmaceuticas que los contienen.
NO20005486D0 (no) Stabil karbonilidblanding og fremgangsmÕte for fremstilling av denne
TH33288A (th) เส้นใยในคอนเฟกชันที่มีฐานของไขมัน